Native rhIGF-1 (mecasermin, brand name Increlex) is FDA-approved only for the long-term treatment of growth failure in pediatric patients with severe primary IGF-1 deficiency or with GH gene deletion who have developed neutralizing antibodies to GH
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine
Talk with a healthcare provider first, or avoid THC gummies completely, if: Your doctor told you not to use cannabis or hemp-derived products
Unlike CJC-1295 with DAC, the no-DAC variant does not include the Drug Affinity Complex for albumin binding, resulting in a shorter half-life of approximately 30 minutes and a more physiologically pulsatile GH release profile in research models
Resources We Trust Mayo Clinic Minute: Weaning Off Popular Weight-Loss Medications Mayo Clinic: UCLA Health: Is It Safe to Pause Taking Ozempic to Indulge in Holiday Festivities